RBM10 and ovarian carcinoma: Conversely, we detected {TP53, CBL, NFKBIE, RBM10} as OV-specific drivers, and the first three are components of the TNFR1 pathway that exerts indirect cytotoxic effects on ovarian cancer stem cells [49].